Literature DB >> 17595061

c-myc promoter binding protein regulates the cellular response to an altered glucose concentration.

Kara C Sedoris1, Shelia D Thomas, Donald M Miller.   

Abstract

Alpha-enolase is a bifunctional gene encoding both a glycolytic enzyme and a DNA binding protein, c-myc binding protein (MBP-1). MBP-1 binds the c-myc promoter and downregulates c-myc transcription. Since these alpha-enolase gene products have important functions in glucose metabolism and growth regulation, this gene may play a central role in regulating the abnormal proliferative characteristics of transformed cells. To determine the role of alpha-enolase and MBP-1 in the cellular response to altered exogenous glucose concentration, MCF-7 cells were cultured in low (1 nM), physiological (5 mM), or high (25 mM) levels of glucose. Levels of alpha-enolase, MBP-1, and c-myc expression were compared to levels of cell proliferation and lactate production. At all glucose concentrations, MCF-7 cells demonstrated an initial increase in MBP-1 expression and a parallel decrease in c-myc transcript levels, which were accompanied by decreased proliferation. Cells grown in low glucose maintained the increased MBP-1 expression through 48 h, resulting in persistently lower rates of proliferation. However, physiologic or high glucose levels resulted in decreased MBP-1 expression, which was associated with increased cellular proliferation and lactate production. In these cells, c-myc mRNA returned to control levels as MBP-1 expression decreased. Cells grown in low glucose demonstrated a dramatic increase in c-myc mRNA at 48 h, which was associated with a loss in c-myc P2 promoter binding by MBP-1. This suggests that post-translational modifications of MBP-1 likely alter its DNA binding activity. These results demonstrate an important role for MBP-1 in the altered cell proliferation and energy utilization that occur in response to an altered glucose concentration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17595061     DOI: 10.1021/bi7003558

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Chemical unfolding of enolase from Saccharomyces cerevisiae exhibits a three-state model.

Authors:  Dénison S Sánchez-Miguel; Jahir Romero-Jiménez; César A Reyes-López; Ana Lilia Cabrera-Avila; Normande Carrillo-Ibarra; Claudia G Benítez-Cardoza
Journal:  Protein J       Date:  2010-01       Impact factor: 2.371

2.  Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.

Authors:  Lakshmi Reddy Palam; Raghuveer Singh Mali; Baskar Ramdas; Sridhar Nonavinkere Srivatsan; Valeria Visconte; Ramon V Tiu; Bart Vanhaesebroeck; Axel Roers; Alexander Gerbaulet; Mingjiang Xu; Sarath Chandra Janga; Clifford M Takemoto; Sophie Paczesny; Reuben Kapur
Journal:  JCI Insight       Date:  2018-02-22

3.  Relationships between LDH-A, lactate, and metastases in 4T1 breast tumors.

Authors:  Asif Rizwan; Inna Serganova; Raya Khanin; Hazem Karabeber; Xiaohui Ni; Sunitha Thakur; Kristen L Zakian; Ronald Blasberg; Jason A Koutcher
Journal:  Clin Cancer Res       Date:  2013-07-05       Impact factor: 12.531

4.  Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors.

Authors:  Jason M God; Christine Cameron; Janette Figueroa; Shereen Amria; Azim Hossain; Bettina Kempkes; Georg W Bornkamm; Robert K Stuart; Janice S Blum; Azizul Haque
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 5.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

6.  Hypoxia induces differential translation of enolase/MBP-1.

Authors:  Kara C Sedoris; Shelia D Thomas; Donald M Miller
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

7.  Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis.

Authors:  Beth Malcomson; Hollie Wilson; Eleonora Veglia; Gayathri Thillaiyampalam; Ruth Barsden; Shauna Donegan; Amal El Banna; Joseph S Elborn; Madeleine Ennis; Catriona Kelly; Shu-Dong Zhang; Bettina C Schock
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-10       Impact factor: 11.205

Review 8.  Interaction of aldehydes derived from lipid peroxidation and membrane proteins.

Authors:  Stefania Pizzimenti; Eric Ciamporcero; Martina Daga; Piergiorgio Pettazzoni; Alessia Arcaro; Gianpaolo Cetrangolo; Rosalba Minelli; Chiara Dianzani; Alessio Lepore; Fabrizio Gentile; Giuseppina Barrera
Journal:  Front Physiol       Date:  2013-09-04       Impact factor: 4.566

9.  Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.

Authors:  Mariavera Lo Presti; Arianna Ferro; Flavia Contino; Claudia Mazzarella; Silvia Sbacchi; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Paola Migliorini; Antonio Marrazzo; Salvatore Feo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer.

Authors:  Flavia Contino; Claudia Mazzarella; Arianna Ferro; Mariavera Lo Presti; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Salvatore Feo
Journal:  BMC Cancer       Date:  2013-02-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.